Lecture material Flashcards

(27 cards)

1
Q

When is the earliest you can patent a drug?

A

Lead discovery, but more reasonable to patent at lead optimization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When is the latest you can patent a drug?

A

Pre-clinical; before you apply for a clinical trial bc at that point the information is public

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a lead?

A

A chemical compound likely to be therapeutically useful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a hit?

A

A compound with desired activity during screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a target?

A

A protein in the body causing disease. Involved with the progression of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is screening?

A

Quality/integrity of a hit or a lead. Elimination of harmful or useless compounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is MOA?

A

Mode of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is HTS?

A

High throughput screening which is automated testing for a specific target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is in vitro testing?

A

Testing in test tubes, culture, dish

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is in vivo testing?

A

Testing on/in a living organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is in silico testing?

A

Testing the structure or function of a compound by using 3D technology and simulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

From ancient times until the mid-19th century, ID of new drugs was primarily the result of…

A

Serendipity (Unplanned, fortunate, discovery)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ehrlich became the father of modern drug discovery because
A. Discovered chemoreceptors
B. Discovered that chemoreceptors were different between different tissues
C. Treated malaria patients with methylene blue
D. All of the above
E. A and B only

A

E.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What makes past drug discovery different from modern drug discovery?
A. Process is not structured, more luck based
B. No ethical concerns
C. More radical methods
D. Not target based
E. All of the above

A

E.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain the Wistar rat

A

A strain of albino rats. An attempt at a standard
Come in:
- diabetic
- tumour formers (Rochester strain)
- Hypersensitive
- Wistar kyoto (ADD model)
- Myelin-deficient rats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When you discuss “in vivo” testing, you must include the models
A. Gender
B. Sex
C. Diet
D. A and B

A

B.

Gender is only relevant when looking at phenotypes.

17
Q

When is it ok to study a single sex and not the other?

A

If disease/condition is only present in one sex (example: menopause)

18
Q

What makes a good target for drug discovery?

A

A target on a pathogen that isn’t contained in the human body
A target of interest that is common and reachable
A well-characterized disease/target
Something that can be manipulated without harmful effects on the body

19
Q

What are the four classes of macromolecules?

A

Enzymes
GPCRs
Ion channels
Transporters

20
Q

Sources for leads

A

Natural products (plants, marine life, fungi)
Synthetic libraries
Bacteria antibiotics
Genomes and genome mining
Metabolic engineering

21
Q

What are Lipinski’s rule of 5 (Ro5)?

A

rotatable bonds <10

Molecular weight <500 DA
logP < 5 (solubility)
H bond donors <5
H bond acceptors <10
(the following was added by Daniel Veber et al.)
Polar surface area <140 A^2

22
Q

What does a high logP value mean in Ro5?

A

The molecule is more hydrophobic

23
Q

What compounds are acceptions to the Ro5?

A

Antibiotics
Antifungals
Vitamins

24
Q

What is Ro3?

A

Molecular weight <300 DA
LogP < 3
H bond donors <= 3
H bond acceptors <=3
Rotatable bonds <=3

25
When do we use Ro3?
For small molecules that are leads (Before Ro5). We can optimize them later by adding more molecules that follow Ro5.
26
Limitations of target based in vitro screens?
Won't be able to find other targets that may have downstream effect of target of interest Off-target effects that are not in vitro Doesn't take into account the activity of the whole cell Metabolic factors missed
27
What's the difference between secondary and counter screens?
Counter screen - identifies compounds that could interact with those in primary screen hits. Able to detect false positives Secondary screen - Provides additional information to the first screen